Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis
Clinical trial NCT02065622 · COMPLETED
Trial details
- NCT number
- NCT02065622
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-27
- Primary completion
- 2019-09-05
- Enrollment
- 952
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.